S9925: Collecting and Storing Samples From Patients With Lung Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT00920010
First received: June 11, 2009
Last updated: April 17, 2013
Last verified: April 2013
  Purpose

RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be tested in the laboratory.


Condition Intervention
Lung Cancer
Other: biologic sample preservation procedure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Lung Cancer Specimen Repository Protocol, Ancillary

Resource links provided by NLM:


Further study details as provided by Southwest Oncology Group:

Primary Outcome Measures:
  • Establishment of a central lung cancer specimen repository to serve as a resource for current and future scientific studies [ Time Frame: From date of study activation to consolidation of specimen banks ] [ Designated as safety issue: No ]
  • Correlation of clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository [ Time Frame: From date of study activation to consolidation of specimen banks ] [ Designated as safety issue: No ]
  • Test of new hypotheses with the specimens in the repository [ Time Frame: From date of study activation to consolidation of specimen banks ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Fixed tissue in paraffin blocks or slides, slides of buccal brushings, fresh frozen tissue peripheral blood, serum, plasma, white blood cells, and sputum.


Enrollment: 2264
Study Start Date: September 2000
Estimated Study Completion Date: June 2013
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

  • Establish a central lung cancer specimen repository to serve as a resource for current and future scientific studies.
  • Correlate clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository.
  • Test new hypotheses with the specimens in the repository.

OUTLINE: Peripheral blood, sputum, and biopsy specimens are collected from patients. Tissue samples are frozen and stored in a lung cancer specimen repository for later use in correlative studies.

PROJECTED ACCRUAL: Not specified

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Lung cancer patients registered to SWOG lung protocols.

Criteria

DISEASE CHARACTERISTICS:

  • Enrolled on one of the following Southwest Oncology Group protocols:

    • SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509, SWOG-S9900, SWOG-S0003, SWOG-S0023, SWOG-S0126, SWOG-S0435, SWOG-S0220, SWOG-S0222, SWOG-S0327, SWOG-S0310, SWOG-S0339, SWOG-S0342, SWOG-S0341, SWOG-S0509, SWOG-S0429, or SWOG-S0124

PATIENT CHARACTERISTICS: Not specified

PRIOR CONCURRENT THERAPY: Not specified

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00920010

  Show 431 Study Locations
Sponsors and Collaborators
Southwest Oncology Group
Investigators
Study Chair: Wilbur A. Franklin, MD University of Colorado, Denver
  More Information

Additional Information:
No publications provided

Responsible Party: Southwest Oncology Group
ClinicalTrials.gov Identifier: NCT00920010     History of Changes
Other Study ID Numbers: CDR0000078624, S9925, U10CA032102
Study First Received: June 11, 2009
Last Updated: April 17, 2013
Health Authority: United States: Federal Government

Keywords provided by Southwest Oncology Group:
non-small cell lung cancer
small cell lung cancer

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on September 16, 2014